NCT04775225View on ClinicalTrials.gov

Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 6, 2021

Primary Completion Date

April 6, 2021

Study Completion Date

April 6, 2021

Conditions
Juvenile Idiopathic ArthritisHip Arthritis
Interventions
DRUG

Lidocaine

denervation of the obturator and femoral genicular branches by Lidocaine 2 %

DRUG

Placebo

an equivalent amount of saline will be injected subcutaneously in 2 points similar to the active group

DRUG

Steroid

Intra-articular injection of 80mg of triamcinolone

Trial Locations (1)

82749

ahmed Elsaman, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT04775225 - Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis | Biotech Hunter | Biotech Hunter